Suppr超能文献

多囊卵巢综合征患者肠道微生物群的特征及其与代谢异常的关联:综述

Characteristics of Gut Microbiota in Patients with Polycystic Ovary Syndrome and Its Association with Metabolic Abnormalities: A Review.

作者信息

Liu Shuang, Cheng Linqi, Li Sen

机构信息

The Reproductive Laboratory, Shenyang, People's Republic of China.

Department of Biotechnology, Shenyang Medical College, Shenyang, People's Republic of China.

出版信息

Int J Womens Health. 2025 Jul 18;17:2165-2174. doi: 10.2147/IJWH.S522708. eCollection 2025.

Abstract

Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder that has garnered attention in recent years for its intricate relationship with gut microbiota, which plays a significant role in the metabolic abnormalities associated with this condition. This review focuses on the characteristics of gut microbiota in polycystic ovary syndrome (PCOS). By analyzing current literature, we will focus on the alterations in gut microbiota composition, influential factors, and the pathophysiological mechanisms linking gut microbiota and PCOS, diagnostic approaches, therapeutic strategies, as well as controversies and future directions in this field are discussed. Understanding these relationships may provide insights into the disease mechanism and highlight novel treatment strategies for managing PCOS.

摘要

多囊卵巢综合征(PCOS)是一种常见的内分泌紊乱疾病,近年来因其与肠道微生物群的复杂关系而备受关注,肠道微生物群在与该病症相关的代谢异常中起着重要作用。本综述聚焦于多囊卵巢综合征(PCOS)中肠道微生物群的特征。通过分析当前文献,我们将关注肠道微生物群组成的改变、影响因素,以及连接肠道微生物群与PCOS的病理生理机制,讨论该领域的诊断方法、治疗策略以及争议和未来方向。了解这些关系可能有助于深入了解疾病机制,并突出管理PCOS的新治疗策略。

相似文献

1
Characteristics of Gut Microbiota in Patients with Polycystic Ovary Syndrome and Its Association with Metabolic Abnormalities: A Review.
Int J Womens Health. 2025 Jul 18;17:2165-2174. doi: 10.2147/IJWH.S522708. eCollection 2025.
2
Gut Microbiome Composition in Polycystic Ovary Syndrome Adult Women: A Systematic Review and Meta-analysis of Observational Studies.
Reprod Sci. 2024 Jul;31(7):1800-1818. doi: 10.1007/s43032-023-01440-4. Epub 2024 Jan 11.
3
Gut microbiota: a hidden player in polycystic ovary syndrome.
J Transl Med. 2025 Apr 15;23(1):443. doi: 10.1186/s12967-025-06315-7.
4
A systematic review of GLP-1 on anthropometrics, metabolic and endocrine parameters in patients with PCOS.
Womens Health (Lond). 2024 Jan-Dec;20:17455057241234530. doi: 10.1177/17455057241234530.
5
Mechanistic insight into nanomedicine for polycystic ovary syndrome.
Mol Biol Rep. 2025 Jun 21;52(1):618. doi: 10.1007/s11033-025-10709-7.
6
POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Long-term health outcomes in polycystic ovary syndrome.
Reproduction. 2025 Jul 10;170(2). doi: 10.1530/REP-25-0118. Print 2025 Aug 1.
8
Microbial composition across body sites in polycystic ovary syndrome: a systematic review and meta-analysis.
Reprod Biomed Online. 2023 Jul;47(1):129-150. doi: 10.1016/j.rbmo.2023.03.016. Epub 2023 Mar 30.

本文引用的文献

1
The Hypothalamus and Pituitary Gland Regulate Reproduction and Are Involved in the Development of Polycystic Ovary Syndrome.
Neuroendocrinology. 2025;115(3-4):315-334. doi: 10.1159/000543877. Epub 2025 Jan 31.
3
Effects of carvacrol on hormonal, inflammatory, antioxidant changes, and ovarian reserve in polycystic ovary syndrome in Wistar rats.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):4607-4616. doi: 10.1007/s00210-024-03588-5. Epub 2024 Nov 7.
4
Unveiling the complex interplay between gut microbiota and polycystic ovary syndrome: A narrative review.
Clin Nutr. 2024 Dec;43(12):199-208. doi: 10.1016/j.clnu.2024.10.028. Epub 2024 Oct 22.
6
Gut microbiota in women with polycystic ovary syndrome: an individual based analysis of publicly available data.
EClinicalMedicine. 2024 Oct 18;77:102884. doi: 10.1016/j.eclinm.2024.102884. eCollection 2024 Nov.
7
Impact of Gut Microbiota and SCFAs in the Pathogenesis of PCOS and the Effect of Metformin Therapy.
Int J Mol Sci. 2024 Oct 2;25(19):10636. doi: 10.3390/ijms251910636.
8
Role of the AMP-Activated Protein Kinase in the Pathogenesis of Polycystic Ovary Syndrome.
Indian J Clin Biochem. 2024 Oct;39(4):450-458. doi: 10.1007/s12291-023-01139-y. Epub 2023 Jul 5.
10
Targeting the microbiome to improve human health with the approach of personalized medicine: Latest aspects and current updates.
Clin Nutr ESPEN. 2024 Oct;63:813-820. doi: 10.1016/j.clnesp.2024.08.005. Epub 2024 Aug 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验